logo

For the Inventor, By the Inventor

Ellisville, MO, United States of America

Nancy M Gray

This inventor holds 10 USPTO granted patents. Top assignees: G.d. Searle & Company, The United States of America as Represented by the Department of Health, C. D. Searle & Co.. Active years: 1991-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nancy M Gray. Retrieved from https://idiyas.com/inventor/nancy-m-gray-c6c5b7fw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 121(Granted Patents)


Location History:

  • Ellisville, MO (US) (1992 - 1997)
  • Buffalo Grove, IL (US) (1991 - 1998)

Company Filing History:

goldMedal8 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal2 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
bronzeMedal1 out of 6 
 
C. D. Searle & Co.
 patents
4. 1 out of 3,696 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
where one patent can have more than one assignee

Years Active: 1991-1998

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5739158 - Nitrogen-containing cyclohetero cycloalkylaminoaryl derivatives for CNS (1998-04-14),
2. 5604255 - N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injury (1997-02-18),
3. 5401755 - N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injury (1995-03-28),
4. 5229413 - Compositions containing indole-2-carboxylate compounds for treatment of (1993-07-20),
5. 5215992 - Ethanobicyclic amine derivatives for CNS disorders (1993-06-01),
6. 5137910 - Compositions containing indole-2-carboxylate compounds for treatment of (1992-08-11),
7. 5130330 - Nitrogen-containing cyclohetero cycloalkylaminoaryl derivatives for CNS (1992-07-14),
8. 5098916 - Propanobicyclic amine derivatives for CNS disorders (1992-03-24),
9. 5089506 - Ethanobicyclic amine derivatives for CNS disorders (1992-02-18),
10. 5055468 - Use of bridged tricyclic amine derivatives as anti-ischemic agents (1991-10-08),

Sure, this is great information. Let's get started with the article.

Title: The Innovative Mind of Inventor Nancy M Gray

Introduction: Nancy M Gray, hailing from Ellisville, MO, is a brilliant inventor who has contributed significantly to the field of neuroscience and pharmacology with her groundbreaking patents.

Latest Patents:

1. **Nitrogen-containing cyclohetero cycloalkylaminoaryl derivatives for CNS:** Nancy's patent revolves around compounds useful in controlling brain damage associated with stroke or cardiac arrest.

2. **N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injury:** Her invention focuses on treating neurotoxic injuries by administering specific compounds to inhibit excitotoxic actions in the brain.

Career Highlights: Nancy has an impressive portfolio of 10 patents, showcasing her dedication to innovation in the medical field. She has worked with renowned companies such as G.D. Searle & Company and The United States of America, Department of Health.

Collaborations: Throughout her career, Nancy has collaborated with talented individuals like Brian K Cheng and Patricia C Contreras, reflecting her ability to work effectively in a team to bring about groundbreaking advancements in the field.

Conclusion: Nancy M Gray's contributions to neuroscience and pharmacology through her patents have been invaluable. Her innovative approach to treating brain injuries and disorders has paved the way for new possibilities in the medical industry, solidifying her position as a visionary inventor.

I hope this article encapsulates the essence of Nancy M Gray's innovative spirit and contributions to the field of neuroscience and pharmacology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…